NEWS

Press Releases, Meetings & Company News

NEWS

Press Releases & Meetings

NEWS

Press Releases & Meetings

MIRACOR ANNOUNCES FDA IDE APPROVAL

FOR PiCSO PIVOTAL STUDY

READ MORE
ClinicalTrials.gov

MIRACOR SYMPOSIUM AT CRT 2022 – IMPACTING AMI OUTCOMES: NEW PARADIGM & LEARNINGS

PANEL: Azeem Latib, Gregg W. Stone, Timothy D. Henry, Morton J. Kern 

RECORDED SYMPOSIUM

PRESSURE-CONTROLLED INTERMITTENT CORONARY OCCLUSION IMPROVES THE VASODILATORY MICROVASCULAR CAPACITY AND REDUCES MYOCARDIAL INJURY IN PATIENTS WITH STEMI.

Scarsini R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, Borlotti A, Marin F, Langrish J, Lucking A, Ribichini F; OxAMI Study, Kharbanda R, Ferreira VM, Channon KM, De Maria GL, Banning AP. 

MORE DETAILS

Meet us at

TCT 2022

Sept 16-19, Boston

MORE

Meet us at

Euro PCR 2022

May 17-20, Paris

MORE

“IMPACTING AMI OUTCOMES: NEW PARADIGMS & LEARNINGS” with Gregg W. Stone, Timothy D. Henry, Adrian P. Banning, Morton J. Kern, and Azeem Latib

CRT 2022

Miracor Lunch Symposium

Sunday, Feb. 27, 12:30PM – 1:30 PM ET

AGENDA